Treatment of Revenue-Generating Diseases with Dr. Thomas Seyfried! 363
Nov 2, 2022
auto_awesome
Dr. Thomas Seyfried, an expert in genetics, biochemistry, and neurology, returns to discuss sugar's impact on cancer growth, consequences of starvation, management of epilepsy with the ketogenic diet, challenging the somatic mutation theory of cancer, benefits of a low-carb, carnivorous diet, alternative treatment options for cancer patients, and the launch of Boundless Body Radio Premium Podcast.
Metabolic therapy, specifically a low carbohydrate or ketogenic diet, can be a powerful tool in managing and treating cancer by depriving cancer cells of their main fuel sources and promoting overall patient well-being.
The current cancer treatment model prioritizes profit over patient well-being, leading to ineffective and harmful treatments and devastating adverse effects for many cancer patients.
There is an urgent need for a paradigm shift in cancer research and treatment towards metabolic therapy, which can improve outcomes and minimize the harmful effects of traditional treatments, but this requires substantial systemic changes and a reevaluation of the influence of pharmaceutical companies.
Deep dives
The Importance of Metabolic Therapy for Cancer Treatment
Metabolic therapy, which involves a low carbohydrate or ketogenic diet, can be a powerful tool in managing and treating cancer. The traditional approach of using drugs and radiation has many drawbacks and adverse effects, often causing more harm than good. Metabolic therapy focuses on depriving cancer cells of their main fuel sources, glucose and glutamine, while providing alternative fuel sources like ketones for normal cells. This creates a competitive disadvantage for cancer cells and promotes the overall health and well-being of the patient. However, the medical industry is resistant to adopting this approach, as it threatens the profitability of the current cancer treatment model.
Ineffective Standard of Care and Profit-Driven Industry
The standard of care for cancer treatment, which primarily relies on drugs and radiation, often fails to deliver good outcomes and leads to unnecessary suffering for patients. Despite the existence of metabolic therapy and its potential benefits, the medical industry continues to prioritize profit over patient well-being. Many cancer patients experience devastating adverse effects from treatments like chemotherapy, which severely impact their quality of life. Additionally, the financial interests of pharmaceutical companies and the interplay between the food and pharmaceutical industries further perpetuate this profit-driven approach to cancer treatment.
Urgent Need for a Paradigm Shift
There is an urgent need for a paradigm shift in cancer research and treatment. Metabolic therapy offers a promising alternative that can improve patient outcomes and minimize the harmful effects of traditional cancer treatments. By focusing on a comprehensive approach that combines diet, targeted drugs, and other metabolic interventions, significant progress can be made towards managing and even curing cancer. However, substantial systemic changes are required, including a reevaluation of medical education and the influence of pharmaceutical companies. The current approach to cancer treatment is failing patients, and it is vital to prioritize their well-being over financial gain.
The Theory of Cancer Management is Incorrect
The current theory of cancer management, based on the somatic mutation theory, is incorrect. Cancer is actually a mitochondrial metabolic disease driven by abnormal energy metabolism. Cancer cells have defective mitochondria and therefore cannot use oxygen for energy. Instead, they ferment glucose and glutamine, which are the prime fermentable fuels driving cancer. Targeting the availability of these fuels and transitioning the body to non-fermentable fuels like ketone bodies and fatty acids can effectively treat cancer. However, there is no business model for metabolic therapy, which hinders its implementation.
The Tragic State of Cancer Treatment
The current state of cancer treatment is tragic, with multiple ineffective and toxic approaches. Many patients suffer from the side effects of chemotherapy, radiation, and immunotherapies, which are based on the incorrect somatic mutation theory. The standard of care fails to address the underlying biology of cancer and does not target the main fuels driving cancer growth. Metabolic therapy, which focuses on nutrition and non-toxic interventions, can be a more effective and personalized approach. However, there is a lack of education and training in this area, creating a gap in healthcare.
Check out our new Patreon page! Get access to the Boundless Body Radio Premium Podcast, with a new episode added every other week! Other perks include early releases of our episodes, extended video content, and group and one on one coaching!
Let the title of this episode sink in as you listen to this one.
Dr. Thomas Seyfried is a returning guest on our show! Be sure to check out his first appearance on Boundless Body Radio on episode 60, which one of the most fascinating discussions we’ve ever had, all about cancer as a metabolic disease! Thomas N. Seyfried received his Ph.D. in Genetics and Biochemistry from the University of Illinois, Urbana, in 1976. He was a Postdoctoral Fellow in the Department of Neurology at the Yale University School of Medicine and then served on the faculty as an Assistant Professor in Neurology. Other awards and honors have come from such diverse organizations as the American Oil Chemists Society, the National Institutes of Health, The American Society for Neurochemistry, the Ketogenic Diet Special Interest Group of the American Epilepsy Society, the Academy of Comprehensive and Complementary Medicine, and the American College of Nutrition. Dr. Seyfried has over 150 peer-reviewed publications and is the author of the book, Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer (Wiley, 1st ed., 2012).
